|
|
Article: Dr. Reddy's Laboratories Limited Announce Agreement For Utilizing Incyte LifeSeq Gold Online.
- Article from:
- Business Wire
- Article date:
- November 20, 2001
CopyrightCOPYRIGHT 2001 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors & Health/Medical Writers
PALO ALTO, Calif., HYDERABAD, India & ATLANTA--Nov. 20, 2001--
LifeSeq(R) Gold to Further Advance Dr. Reddy's Research and Development Programs in Cancer, Diabetes, Infectious Diseases and Pain
Therapeutic Development Through Genomics
Dr. Reddy's Laboratories Limited (NYSE: RDY), an emerging global pharmaceutical company, and Reddy US Therapeutics, Inc. ("Reddy US"), a wholly-owned subsidiary of Dr. Reddy's, and Incyte Genomics, Inc. (Nasdaq: INCY), the leading genomic information company, today announced the signing of a collaborative agreement allowing Dr. Reddy's and Reddy US access to ...